Cargando…

Effectiveness of bivalent COVID-19 boosters against COVID-19 mortality in people aged 65 years and older, Australia, November 2022 to May 2023

We followed 4,081,257 Australian adults aged ≥ 65 years between November 2022 and May 2023 for COVID-19-specific mortality, when recombinant SARS-CoV-2 Omicron lineages (predominantly XB and XBB) as well as BA.2.75 were circulating. Compared with a COVID-19 booster targeting ancestral SARS-CoV-2 giv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Bette, Stepien, Sandrine, Sharma, Ketaki, Macartney, Kristine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2023
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668254/ https://www.ncbi.nlm.nih.gov/pubmed/37997663 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.47.2300603

Ejemplares similares

COVID-19 Vaccine Uptake by Infection Status in New South Wales, Australia
por: Gidding, Heather F., et al.
Publicado: (2023)

COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults — United States, November–December 2022
por: Lu, Peng-jun, et al.
Publicado: (2023)

Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
por: Huiberts, Anne J, et al.
Publicado: (2023)

Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults — United States, November 1–December 10, 2022
por: Sinclair, Alyssa H., et al.
Publicado: (2023)

Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022
por: Fabiani, Massimo, et al.
Publicado: (2023)

Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020
por: Sullivan, Sheena G, et al.
Publicado: (2020)

Wild poliovirus type 3 (WPV3)-shedding event following detection in environmental surveillance of poliovirus essential facilities, the Netherlands, November 2022 to January 2023
por: Duizer, Erwin, et al.
Publicado: (2023)

Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection
por: Liu, Bette, et al.
Publicado: (2022)

Two cases of extensively drug-resistant (XDR) Neisseria gonorrhoeae infection combining ceftriaxone-resistance and high-level azithromycin resistance, France, November 2022 and May 2023
por: Maubaret, Clara, et al.
Publicado: (2023)

COVID-19 vaccines in 2023
por: Sharma, Ketaki, et al.
Publicado: (2023)

Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023
por: Kim, Ryu Kyung, et al.
Publicado: (2023)

An Assessment of the Bivalent Vaccine as a Second Booster for COVID-19
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Axillary lymphadenopathy following bivalent COVID-19 booster vaccination
por: Lane, Elizabeth G., et al.
Publicado: (2023)

Cryptic SARS-CoV-2 lineage identified on two mink farms as a possible result of long-term undetected circulation in an unknown animal reservoir, Poland, November 2022 to January 2023
por: Domańska-Blicharz, Katarzyna, et al.
Publicado: (2023)

A Bivalent Omicron-Containing Booster Vaccine against Covid-19
por: Chalkias, Spyros, et al.
Publicado: (2022)

Characterizing healthcare worker attitudes toward the bivalent COVID-19 booster
por: Willebrand, Kathryn, et al.
Publicado: (2023)

Understanding a national increase in COVID-19 vaccination intention, the Netherlands, November 2020–March 2021
por: Sanders, Jet G., et al.
Publicado: (2021)

Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021
por: Ireland, Georgina, et al.
Publicado: (2022)

Monkeypox infection presenting as genital rash, Australia, May 2022
por: Hammerschlag, Yael, et al.
Publicado: (2022)

Study on the COVID-19 epidemic in mainland China between November 2022 and January 2023, with prediction of its tendency
por: Bai, Yao, et al.
Publicado: (2023)

Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023
por: Fabiani, Massimo, et al.
Publicado: (2023)

Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies
por: Carreño, Juan Manuel, et al.
Publicado: (2023)

2334. The effectiveness of bivalent COVID-19 booster among patients with hematologic malignancies
por: Aleissa, Muneerah M, et al.
Publicado: (2023)

Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
por: Sentís, Alexis, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020
por: Maurer, Florian P, et al.
Publicado: (2021)

Early assessment of the impact of mitigation measures to control COVID-19 in 22 French metropolitan areas, October to November 2020
por: Spaccaferri, Guillaume, et al.
Publicado: (2020)

Unexposed populations and potential COVID-19 hospitalisations and deaths in European countries as per data up to 21 November 2021
por: Chapman, Lloyd A C, et al.
Publicado: (2022)

COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: cohort study based on electronic health records, Portugal, May to July 2022
por: Kislaya, Irina, et al.
Publicado: (2022)

Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022
por: Vallejo-Plaza, Alberto, et al.
Publicado: (2022)

Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study
por: Liu, Bette, et al.
Publicado: (2023)

Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22
por: Bosetti, Paolo, et al.
Publicado: (2022)

Severe and fatal neonatal infections linked to a new variant of echovirus 11, France, July 2022 to April 2023
por: Grapin, Mathilde, et al.
Publicado: (2023)

Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020
por: Brandal, Lin T, et al.
Publicado: (2021)

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022
por: Eggink, Dirk, et al.
Publicado: (2022)

Ongoing measles outbreaks in Romania, March 2023 to August 2023
por: Lazar, Mihaela, et al.
Publicado: (2023)

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
por: Rosenblum, Hannah G., et al.
Publicado: (2022)

Changes in COVID-19 outbreak severity and duration in long-term care facilities following vaccine introduction, England, November 2020 to June 2021
por: Giddings, Rebecca, et al.
Publicado: (2021)

Rebound in community antibiotic consumption after the observed decrease during the COVID-19 pandemic, EU/EEA, 2022
por: Ventura-Gabarró, Cèlia, et al.
Publicado: (2023)

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
por: Surie, Diya, et al.
Publicado: (2022)

Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021
por: Marrone, Gaetano, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ftt67c0q6sokpgn7557tqhnuc